We are live on ! Find out more
ALT icon

Altimmune
ALT

132 hedge funds and large institutions have $205M invested in Altimmune in 2023 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $26.6M | Put options by funds: $14.9M

65% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 31

13% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 32

3% more funds holding

Funds holding: 128 → 132 (+4)

7.16% less ownership

Funds ownership: 95.24% → 88.08% (-7.2%)

80% less capital invested

Capital invested by funds: $1.03B → $205M (-$826M)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
51
Reduced
31
Closed
32
Calls
$26.6M
Puts
$14.9M
Net Calls
+$11.6M
Net Calls Change
-$41M

Top Buyers

1
LCM
Laurion Capital Management
New York
+$32.7M
2
Millennium Management
Millennium Management
New York
+$11M
3
Citadel Advisors
Citadel Advisors
Florida
+$10.5M
4
AAP
Ardsley Advisory Partners
Connecticut
+$8.82M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$7.96M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$45.3M
2
CAM
Cormorant Asset Management
Massachusetts
-$42.8M
3
APM
Avidity Partners Management
Texas
-$31.8M
4
WP
Woodline Partners
California
-$21.5M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$17.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
OQS
26
Occudo Quantitative Strategies
Florida
$1.83M +$5.16M +434,048 New
GCP
27
GSA Capital Partners
United Kingdom
$1.75M +$4.45M +374,233 +899%
Citigroup
28
Citigroup
New York
$1.74M +$1.43M +120,745 +41%
CM
29
Caption Management
Oklahoma
$1.69M +$4.13M +347,896 +668%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$1.43M +$2.78M +234,091 +223%
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$1.38M +$2.76M +232,362 +246%
SFM
32
Sphera Funds Management
Israel
$1.27M -$954K -80,298 -21%
JF
33
Jump Financial
Illinois
$1.22M +$3.43M +288,700 New
Renaissance Technologies
34
Renaissance Technologies
New York
$1.17M -$2.75M -231,700 -46%
SSA
35
Schonfeld Strategic Advisors
New York
$1.16M +$3.26M +274,441 New
BWCS
36
Beirne Wealth Consulting Services
Connecticut
$1.05M +$147K +12,400 +5%
Barclays
37
Barclays
United Kingdom
$957K -$1.6M -134,380 -37%
RSCM
38
Rock Springs Capital Management
Maryland
$942K – – –
Squarepoint
39
Squarepoint
New York
$904K +$2.55M +214,264 New
Jane Street
40
Jane Street
New York
$771K -$741K -62,388 -25%
BFM
41
Boothbay Fund Management
New York
$742K +$1.47M +123,618 +237%
KCM
42
Knoll Capital Management
Florida
$734K – – –
HF
43
HRT Financial
New York
$695K +$1.96M +164,768 New
UBS Group
44
UBS Group
Switzerland
$684K -$2.62M -220,871 -58%
Northern Trust
45
Northern Trust
Illinois
$599K +$25.2K +2,121 +2%
Group One Trading
46
Group One Trading
Illinois
$503K -$673K -56,611 -32%
Swiss National Bank
47
Swiss National Bank
Switzerland
$448K -$145K -12,200 -10%
SAM
48
Silvercrest Asset Management
New York
$437K +$487K +41,000 +66%
CSS
49
Cubist Systematic Strategies
Connecticut
$420K +$1.18M +99,468 New
PIM
50
Platinum Investment Management
Australia
$401K -$281K -23,649 -20%
1
2
3 4 5

ALT Hedge Fund Activity: Q1 2023 in Review

132 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2023, worth a combined $205M — down 80% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ALT positions and 32 closed out — a net gain of 4 holders — while 51 added to existing stakes and 31 trimmed.

The largest buyer was Laurion Capital Management, adding an estimated $32.7M. The largest seller was Janus Henderson Group, cutting an estimated $45.3M.

  • 132 institutional investors held Altimmune (ALT) as of Q1 2023, up from 128 in Q4 2022.
  • Funds reported $205M of Altimmune stock for Q1 2023, down 80% quarter-over-quarter.
  • 36 funds opened new Altimmune positions in Q1 2023 and 32 closed out, a net change of +4 holders.
  • The largest Altimmune buyer in Q1 2023 was Laurion Capital Management, an estimated $32.7M added.
  • The largest Altimmune seller in Q1 2023 was Janus Henderson Group, an estimated $45.3M sold.

Based on aggregated 13F filings for Q1 2023.